August 16, 2017 11:38 AM ET

Biotechnology

Company Overview of Idera Pharmaceuticals, Inc.

Executive Profile

Julian Charles Baker

Executive Director of Market Development and Director, Idera Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 7 different industries.

See Board Relationships
50$70,252

Background

Mr. Julian Charles Baker, also known as Jim, has been an Executive Director of Market Development at Idera Pharmaceuticals, Inc. since January 2015. Mr. Baker serves as Managing Partner at Baker Brothers Advisors LP and Baker Brothers Investments. He co-founded Baker Brothers Investments in 2000. Mr. Baker is a Managing Partner of Baker-Tisch Investments. He serves as Co-Managing Member of Baker Bros. Advisors, LLC. Mr. Baker served as Executive Director of Corporate ...

Corporate Headquarters

167 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-679-5500
Fax: 617-679-5592

Board Members Memberships

Director
2001-Present
Vice Chairman and Lead Independent Director
2001-Present
Lead Independent Director
2014-Present
Executive Director of Market Development and Director
2015-Present
Independent Director

Education

BA
Harvard University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$35,000
Total Calculated Compensation$70,252
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Idera Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.